We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Move away from unprofitable hardware peddler to fitness provider starts to pay off
Connected fitness company says the figure is 2,299 times higher than the median employee salary
Two other executives step down from connected fitness company in management shake-up
Latest results confirm how disastrous the capital-intensive model of the US fitness group has become
Chief portrays decision as natural progression towards simplifying its supply chain
Peloton sweetens deal for staff as it embarks on ambitious turnround plan
Raising money is much trickier today, as Peloton has found out
Debt sold at top of market by groups such as Peloton and Spotify is hit by rising rates and sinking equities
Days inventory ratio shows the pile-up in unsold merch
Apollo and Blackstone are among participants in $750mn financing for connected fitness company
Chief ‘not sure yet’ about aspects of growth strategy as stationary bike maker’s revenue declines
Fitness company’s shares fall after reporting net loss of $757.1mn and disappointing guidance
Despairing shareholders, stuck on a downhill ride to nowhere, would surely welcome an exit
Plus, Microsoft lands on regulators’ radars in the EU
Blackwells Capital says Barry McCarthy has failed to reform governance at fitness company
Falls have proved ‘wicked punishment’ for managers holding Peloton, Zoom and other high-growth bets
Sale to Michael Dell-backed investment firm is largest since John Foley was ousted as fitness company’s chief
Banks lending to clients whose equity is collateral is good for both — until share prices collapse
Company insiders tell the FT that executives hatched a scheme to cover up corrosion and avoid a costly recall
It was a darling with investors and customers. What went wrong?
Company’s shares fall as much as 5 per cent after Barry McCarthy rebuffs calls to find buyer
Clinical number-cruncher has built his four-decade career as the adult in a room of young tech companies
Share price surge reflects Wall Street hope for a deal, but co-founder retains control as he moves to stave off suitors
Biotech groups face cash crunch after a ‘bloodbath’ in the stock market as investors dump shares
If a fraction of Prime members were to subscribe, sales of the fitness bike maker would soar
UK Edition
